24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
85.71% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
14.29% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
94.15% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
2.42% |
|
ENZYME DYNAMICS |
2.02% |
|
CANCER |
1.41% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
60.41% |
|
ANTIBODY DYNAMICS SIMULATION |
14.11% |
|
INFLUENZA |
9.4% |
|
ENZYME DYNAMICS |
5.36% |
|
CANCER |
3.19% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
1.36% |
|
RCA STABILITY SIMULATIONS |
1.19% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
1% |
|
MEMBRANE TRANSPORT |
.96% |
|
RCA OLIGOMERIC STABILITY HEAT STRESS SIMULATIONS |
.81% |
|
RCA TEMPERATURE STABILITY SIMULATIONS |
.79% |
|
RCA OLIGOMERIC STABILITY SIMULATIONS |
.58% |
|
ANTIBODY AFFINITY MATURATION |
.58% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
.25% |